Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.700
-0.040 (-2.30%)
Apr 21, 2026, 1:53 PM EDT - Market open

PACB Revenue

In the year 2025, Pacific Biosciences of California had annual revenue of $160.01M with 3.89% growth. Pacific Biosciences of California had revenue of $44.65M in the quarter ending December 31, 2025, with 13.82% growth.

Revenue (ttm)
$160.01M
Revenue Growth
+3.89%
P/S Ratio
3.20
Revenue / Employee
$329,907
Employees
485
Market Cap
513.40M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025160.01M5.99M3.89%
Dec 31, 2024154.01M-46.51M-23.19%
Dec 31, 2023200.52M72.22M56.29%
Dec 31, 2022128.30M-2.21M-1.69%
Dec 31, 2021130.51M51.62M65.43%
Dec 31, 202078.89M-12.00M-13.20%
Dec 31, 201990.89M12.27M15.60%
Dec 31, 201878.63M-14.84M-15.88%
Dec 31, 201793.47M2.75M3.04%
Dec 31, 201690.71M-2.07M-2.23%
Dec 31, 201592.78M32.19M53.12%
Dec 31, 201460.59M32.41M115.02%
Dec 31, 201328.18M2.20M8.46%
Dec 31, 201225.98M-7.88M-23.27%
Dec 31, 201133.86M32.19M1,922.88%
Dec 31, 20101.67M1.54M1,140.00%
Dec 31, 2009135.00K-766.00K-85.02%
Dec 31, 2008901.00K-1.26M-58.34%
Dec 31, 20072.16M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Varex Imaging854.40M
Orthofix Medical822.31M
Tactile Systems Technology329.52M
OrthoPediatrics236.35M
Cerus206.13M
Cytek Biosciences201.49M
SI-BONE200.93M
Beta Bionics100.25M
Revenue Rankings